CytoSorbents Corp (CTSO) - Financial and Strategic SWOT Analysis Review



CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed to control extreme systemic inflammation in seriously ill patients by reducing excessive cytokines and bacterial toxins. CytoSorbents’ CytoSorb is also being administered during and after cardiac surgery to prevent post-operative complications such as multiple organ failure. The company offers VetResQ, a blood purification adsorber, to support and treat excessive inflammation and toxic injury in animals. The company offers its products through a network of distributors across Europe, the Middle East and Asia Pacific. CytoSorbents is headquartered in Monmouth Junction, New Jersey, the US.

CytoSorbents Corp Key Recent Developments

May 05,2020: CytoSorbents reports first quarter 2020 financial and operational results
May 04,2020: CytoSorbents promotes Vincent J. Capponi to president
Apr 29,2020: CytoSorbents receives $1.1 million in non-dilutive funding from the New Jersey Business Tax Certificate Transfer Program, returning $1.4 million received from Paycheck Protection Program
Apr 27,2020: Cytosorbents appoints Dr. Efthymios N. Deliargyris, M.D., as Chief Medical Officer
Mar 31,2020: CytoSorb Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care

This comprehensive SWOT profile of CytoSorbents Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CytoSorbents Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

CytoSorbents Corp - Key Information
CytoSorbents Corp - Overview
CytoSorbents Corp - Key Employees
CytoSorbents Corp - Key Employee Biographies
CytoSorbents Corp - Key Operational Heads
CytoSorbents Corp - Major Products and Services
CytoSorbents Corp - History
CytoSorbents Corp - Company Statement
CytoSorbents Corp - Locations And Subsidiaries
CytoSorbents Corp
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

CytoSorbents Corp - Business Description
CytoSorbents Corp - Corporate Strategy
CytoSorbents Corp - SWOT Analysis
SWOT Analysis - Overview
CytoSorbents Corp - Strengths
CytoSorbents Corp - Weaknesses
CytoSorbents Corp - Opportunities
CytoSorbents Corp - Threats
CytoSorbents Corp - Key Competitors

Section 3 - Company Financial Performance Charts

CytoSorbents Corp - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



CytoSorbents Corp, Key Information
CytoSorbents Corp, Key Ratios
CytoSorbents Corp, Share Data
CytoSorbents Corp, Major Products and Services
CytoSorbents Corp, History
CytoSorbents Corp, Key Employees
CytoSorbents Corp, Key Employee Biographies
CytoSorbents Corp, Key Operational Heads
CytoSorbents Corp, Other Locations
CytoSorbents Corp, Subsidiaries
CytoSorbents Corp, Key Competitors
CytoSorbents Corp, SWOT Analysis
CytoSorbents Corp, Ratios based on current share price
CytoSorbents Corp, Annual Ratios
CytoSorbents Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



CytoSorbents Corp, Performance Chart
CytoSorbents Corp, Ratio Charts
 


CytoSorbents Corp (CTSO) - Product Pipeline Analysis, 2019 Update

CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed

USD 750 View Report

CytoSorbents Corp (CTSO) - Product Pipeline Analysis, 2017 Update

CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine

USD 750 View Report

CytoSorbents Corp (CTSO) - Product Pipeline Analysis, 2019 Update

CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that develops blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine adsorber that is designed

USD 750 View Report

CytoSorbents Corp (CTSO) - Product Pipeline Analysis, 2017 Update

CytoSorbents Corp (CytoSorbents), formerly MedaSorb Technologies Corp, is a critical care immunotherapy company that specializes in the development of blood purification products. Its flagship product, CytoSorb is an extracorporeal cytokine

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available